Dynavax Technologies Share Price Today
(NASDAQ: DVAX)

Name: Dynavax Technologies Share Price Today (NASDAQ: DVAX) - Dynavax Technologies Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Dynavax Technologies share price is $13 & ₹1,132.24 as on 5 Feb 2025, 2.30 'hrs' IST

$13

▲

0.06

(0.46%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Dynavax Technologies share price in Dollar and Rupees. Guide to invest in Dynavax Technologies stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Dynavax Technologies, along with analyst recommendations, forecasts, and comprehensive financials.

Dynavax Technologies share price movements

Today's Low: $12.73
Today's High: $13.07
$13.00
2.12%
Downside
Day's Volatility :2.64%
Upside
0.54%
52 Weeks Low: $9.74
52 Weeks High: $13.89
$13.00
25.08%
Downside
52 Weeks Volatility :29.88%
Upside
6.41%

Dynavax Technologies (DVAX) Returns

Period	Dynavax Technologies Corporation	Sector (Health Care)	Index (Russel 2000)
3 Months	5.29%	0.5%	0.0%
6 Months	20.37%	-2.3%	0.0%
1 Year	-0.31%	3.8%	0.0%
3 Years	1.49%	11.4%	-11.7%

Dynavax Technologies (DVAX) Key Statistics

in dollars & INR

Previous Close	$12.94
Open	$12.9
Today's High	$13.07
Today's Low	$12.725
Market Capitalization	$1.7B
Today's Volume	$1.1M
52 Week High	$13.89
52 Week Low	$9.74
Revenue TTM	$260.8M
EBITDA	$-1.6M
Earnings Per Share (EPS)	$0.15
PE Ratio	86.27
Profit Margin	7.85%
Quarterly Earnings Growth YOY	0.21%
Return On Equity TTM	3.18%

How to invest in Dynavax Technologies Stock (DVAX) from India?

It is very easy for Indian residents to invest directly in Dynavax Technologies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Dynavax Technologies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Dynavax Technologies or DVAX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Dynavax Technologies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Dynavax Technologies shares which would translate to 0.067 fractional shares of Dynavax Technologies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Dynavax Technologies, in just a few clicks!

Returns in Dynavax Technologies (DVAX) for Indian investors in Rupees

The Dynavax Technologies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Dynavax Technologies investment value today

Current value as on today

₹1,05,019

Returns

₹5,019

(+5.02%)

Returns from Dynavax Technologies Stock

₹154 (+0.15%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Dynavax Technologies (DVAX)

-63%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Dynavax Technologies Stock from India on INDmoney has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Dynavax Technologies

BlackRock Inc
15.94%
Deep Track Capital, LP
9.53%
Vanguard Group Inc
7.01%
Kynam Capital Management, LP
6.34%
State Street Corp
5.85%
Federated Hermes Inc
4.27%

Analyst Recommendation on Dynavax Technologies

Buy

83%Buy

16%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Dynavax Technologies(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Dynavax Technologies Stock (DVAX)

What analysts predicted

Upside of 92.31%

Target:

$25.00

Current:

$13.00

Insights on Dynavax Technologies Stock (Ticker Symbol: DVAX)

Price Movement
In the last 3 months, DVAX stock has moved up by 9.8%
Increasing Revenue
Revenue is up for the last 3 quarters, 50.79M → 80.63M (in $), with an average increase of 19.8% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -8.72M → 17.59M (in $), with an average increase of 105.9% per quarter
DVAX vs ITCI (1 yr)
In the last 1 year, Intra-cellular Therapies, Inc. has given 89.1% return, outperforming this stock by 87.6%
DVAX vs ITCI (3 yr)
In the last 3 years, Intra-cellular Therapies, Inc. has given 161.1% return, outperforming this stock by 158.6%
Price to Sales
ForDVAX every $1 of sales, investors are willing to pay $6.5, whereas for Intra-cellular Therapies, Inc., the investors are paying $20.9 for every $1 of sales.

DVAX Dynavax Technologies Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$8.2M	↑ 2407.03%
Net Income	$-158.9M	↑ 66.99%
Net Profit Margin	-1.9K%	↑ 27160.81%

	FY19	Y/Y Change
Revenue	$35.2M	↑ 329.6%
Net Income	$-151.4M	↓ 4.72%
Net Profit Margin	-429.87%	↑ 1508.4%

	FY20	Y/Y Change
Revenue	$46.6M	↑ 32.18%
Net Income	$-91.8M	↓ 39.38%
Net Profit Margin	-197.15%	↑ 232.72%

	FY21	Y/Y Change
Revenue	$439.4M	↑ 844.0%
Net Income	$76.7M	↓ 183.59%
Net Profit Margin	17.46%	↑ 214.61%

	FY22	Y/Y Change
Revenue	$722.7M	↑ 64.45%
Net Income	$293.2M	↑ 282.15%
Net Profit Margin	40.56%	↑ 23.1%

	FY23	Y/Y Change
Revenue	$232.3M	↓ 67.86%
Net Income	$-6.4M	↓ 102.18%
Net Profit Margin	-2.75%	↓ 43.31%

	Q2 FY23	Q/Q Change
Revenue	$60.2M	↑ 28.39%
Net Income	$3.4M	↓ 114.1%
Net Profit Margin	5.69%	↑ 57.54%

	Q3 FY23	Q/Q Change
Revenue	$69.5M	↑ 15.38%
Net Income	$14.3M	↑ 316.58%
Net Profit Margin	20.56%	↑ 14.87%

	Q4 FY23	Q/Q Change
Revenue	$55.6M	↓ 20.02%
Net Income	$219.0K	↓ 98.47%
Net Profit Margin	0.39%	↓ 20.17%

	Q1 FY24	Q/Q Change
Revenue	$50.8M	↓ 8.64%
Net Income	$-8.7M	↓ 4082.19%
Net Profit Margin	-17.17%	↓ 17.56%

	Q2 FY24	Q/Q Change
Revenue	$73.8M	↑ 45.29%
Net Income	$11.4M	↓ 230.56%
Net Profit Margin	15.43%	↑ 32.6%

	Q3 FY24	Q/Q Change
Revenue	$80.6M	↑ 9.26%
Net Income	$17.6M	↑ 54.52%
Net Profit Margin	21.82%	↑ 6.39%

	FY18	Y/Y Change
Profit	$-13.6M	↑ 1468.4%

	FY19	Y/Y Change
Profit	$15.8M	↓ 216.41%

	FY20	Y/Y Change
Profit	$32.6M	↑ 106.2%

	FY21	Y/Y Change
Profit	$265.9M	↑ 714.53%

	FY22	Y/Y Change
Profit	$460.5M	↑ 73.22%

	FY23	Y/Y Change
Profit	$182.1M	↓ 60.45%

	Q2 FY23	Q/Q Change
Profit	$46.7M	↑ 45.01%

	Q3 FY23	Q/Q Change
Profit	$56.3M	↑ 20.49%

	Q4 FY23	Q/Q Change
Profit	$46.9M	↓ 16.66%

	Q1 FY24	Q/Q Change
Profit	$39.8M	↓ 15.1%

	Q2 FY24	Q/Q Change
Profit	$61.8M	↑ 55.21%

	Q3 FY24	Q/Q Change
Profit	$67.5M	↑ 9.28%

	FY18	Y/Y Change
Operating Cash Flow	$-131.3M	↑ 69.38%
Investing Cash Flow	$55.5M	↓ 151.03%
Financing Cash Flow	$99.1M	↓ 47.26%

	FY19	Y/Y Change
Operating Cash Flow	$-121.3M	↓ 7.65%
Investing Cash Flow	$-42.8M	↓ 177.13%
Financing Cash Flow	$154.4M	↑ 55.8%

	FY20	Y/Y Change
Operating Cash Flow	$-92.3M	↓ 23.92%
Investing Cash Flow	$-26.5M	↓ 37.98%
Financing Cash Flow	$109.5M	↓ 29.06%

	FY21	Y/Y Change
Operating Cash Flow	$335.5M	↓ 463.71%
Investing Cash Flow	$14.2M	↓ 153.61%
Financing Cash Flow	$55.8M	↓ 49.06%

	FY22	Y/Y Change
Operating Cash Flow	$62.7M	↓ 81.31%
Investing Cash Flow	$-316.0M	↓ 2321.41%
Financing Cash Flow	$19.5M	↓ 64.99%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$28.0M	↑ 1.54%
Investing Cash Flow	$24.7M	↓ 147.24%
Financing Cash Flow	$-294.0K	↓ 90.49%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$31.1M	↑ 10.99%
Investing Cash Flow	$-106.1M	↓ 529.07%
Financing Cash Flow	$3.0M	↓ 1118.37%

Dynavax Technologies Technicals Summary

Sell

Neutral

Buy

Dynavax Technologies is currently in a neutral trading position according to technical analysis indicators.

Dynavax Technologies (DVAX) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Dynavax Technologies Corporation	1.41%	20.37%	-0.31%	1.49%	59.56%
Intra-cellular Therapies, Inc.	55.53%	72.74%	81.47%	149.54%	495.46%
Haleon Plc Spon Ads	0.32%	-1.35%	13.13%	27.94%	27.94%
Zoetis Inc.	3.64%	-6.94%	-12.34%	-14.17%	23.79%
Neurocrine Biosciences Inc.	9.68%	4.14%	4.99%	85.26%	44.35%
Viatris Inc.	-7.62%	-2.82%	-7.15%	-27.65%	-32.44%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Dynavax Technologies Corporation	86.27	86.27	0.0	0.19	0.03	0.0	NA	5.19
Intra-cellular Therapies, Inc.	NA	NA	0.0	-0.71	-0.1	-0.07	NA	10.8
Haleon Plc Spon Ads	28.7	28.7	1.68	0.36	0.07	0.04	0.02	1.82
Zoetis Inc.	32.18	32.18	2.66	5.89	0.47	0.15	0.01	11.59
Neurocrine Biosciences Inc.	40.03	40.03	0.35	6.59	0.16	0.12	NA	26.87
Viatris Inc.	224.4	NA	0.07	2.68	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Dynavax Technologies Corporation	Buy	$1.7B	59.56%	86.27	7.85%
Intra-cellular Therapies, Inc.	Buy	$13.5B	495.46%	NA	-14.07%
Haleon Plc Spon Ads	Buy	$42.8B	27.94%	28.7	10.75%
Zoetis Inc.	Buy	$77.1B	23.79%	32.18	26.55%
Neurocrine Biosciences Inc.	Buy	$15.2B	44.35%	40.03	17.21%
Viatris Inc.	Hold	$13.5B	-32.44%	224.4	-5.87%

About Dynavax Technologies

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States. It markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. The company also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; Biological E. Limited; PT Bio Farma; Medigen Vaccine Biologics; and Serum Institute of India Pvt. Ltd. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. The company was incorporated in 1996 and is headquartered in Emeryville, California.

Organization	Dynavax Technologies
Employees	408
CEO	Mr. Ryan Spencer
Industry	Health Technology

Management People of Dynavax Technologies

Name	Title
Mr. Ryan Spencer	CEO & Director
Mr. David F. Novack	President & COO
Ms. Kelly MacDonald CPA	Senior VP & CFO
Dr. Robert Janssen M.D.	Chief Medical Officer and Senior VP of Clinical Development, Medical & Regulatory Affairs
Mr. Justin Burgess	Chief Accounting Officer & Controller
Mr. Jeff P. Coon	Senior VP & Chief Human Resources Officer
Mr. Paul Cox	VP of Investor Relations & Corporate Communications
Mr. John L. Slebir	Senior VP & General Counsel
Mr. Donn Casale	Senior VP & Chief Commercial Officer
Dr. Dong Yu	Senior Vice President of Research

Important FAQs about investing in DVAX Stock from India :

What is Dynavax Technologies share price today?

Dynavax Technologies share price today stands at $13.00, Open: $12.90 ; Previous Close: $12.94 ; High: $13.07 ; Low: $12.73 ; 52 Week High: $13.89 ; 52 Week Low: $9.74.

The stock opens at $12.90, after a previous close of $12.94. The stock reached a daily high of $13.07 and a low of $12.73, with a 52-week high of $13.89 and a 52-week low of $9.74.

Can Indians buy Dynavax Technologies shares?

Yes, Indians can invest in the Dynavax Technologies (DVAX) from India.

With INDmoney, you can buy Dynavax Technologies at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Dynavax Technologies at zero transaction cost.

How can I buy Dynavax Technologies shares from India?

It is very easy to buy Dynavax Technologies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Dynavax Technologies (DVAX) be purchased?

Yes, you can buy fractional shares of Dynavax Technologies with INDmoney app.

What are the documents required to start investing in Dynavax Technologies stocks?

To start investing in Dynavax Technologies, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.